Is there any potential or additive effect of anemia on hepatorenal syndrome?

dc.contributor.author	Güngör, G.
dc.contributor.author	Akyildiz, M.
dc.contributor.author	Keskin, M.
dc.contributor.author	Solak, Y.
dc.contributor.author	Gaipov, A.
dc.contributor.author	Biyik, M.
dc.contributor.author	Çifçi, S.
dc.contributor.author	Ataseven, H.
dc.contributor.author	Polat, H.
dc.contributor.author	Demir, A.
dc.date.accessioned	2021-12-21T08:41:32Z
dc.date.available	2021-12-21T08:41:32Z
dc.date.issued	2016
dc.identifier.issn	13004948
dc.identifier.uri	https://doi.org/10.5152/tjg.2016.16029
dc.identifier.uri	http://dspace.yeniyuzyil.edu.tr:8080/xmlui/handle/20.500.12629/1450
dc.description.abstract	Background/Aims: Hepatorenal syndrome (HRS) is a severe complication of advanced cirrhosis and is characterized by renal dysfunction and poor survival rates. Although anemia is a non-rare condition in advanced liver cirrhosis, there is no publication rega
dc.language.iso	English
dc.publisher	Turkish Society of Gastroenterology
dc.rights	All Open Access, Bronze
dc.title	Is there any potential or additive effect of anemia on hepatorenal syndrome?
dc.type	Article
dc.relation.journal	Turkish Journal of Gastroenterology
dc.identifier.issue	3
dc.identifier.startpage	273
dc.identifier.endpage	278
dc.identifier.volume	27
dc.identifier.doi	10.5152/tjg.2016.16029
dc.relation.issue	3
dc.relation.volume	27